Cargando…

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin

Epidermal growth factor-like domain 7 (EGFL7) is a protein specifically secreted by blood vessel endothelial cells, which plays an important role in angiogenesis. Considering the aberrant secretion of EGFL7 in osteosarcoma (OS) has not yet been elucidated, this study investigated the secretion of EG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qing, He, Hongbo, Yuan, Yuhao, Zeng, Hao, Wang, Zhiwei, Luo, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016045/ https://www.ncbi.nlm.nih.gov/pubmed/32117731 http://dx.doi.org/10.3389/fonc.2020.00074

Ejemplares similares

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
por: Liu, Weipeng, et al.
Publicado: (2022)

Effect and Mechanism of EGFL7 Downregulation in Human Osteosarcoma Cells on the Biological Function of Co-cultured HUVEC
por: Li, Xia, et al.
Publicado: (2018)

Prognostic analysis of telangiectatic osteosarcoma of the extremities
por: Zhong, Wei, et al.
Publicado: (2023)

microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7
por: Tu, Jiajie, et al.
Publicado: (2019)

LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus
por: Zhou, Qinbo, et al.
Publicado: (2019)

EGFL7 reduces CNS inflammation in mouse
por: Larochelle, Catherine, et al.
Publicado: (2018)

Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020)

Egfl7 promotes tumor escape from immunity
por: Pinte, Sébastien, et al.
Publicado: (2012)

The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance
por: Heissig, Beate, et al.
Publicado: (2021)

Egfl7 Is Differentially Expressed in Arteries and Veins during Retinal Vascular Development
por: Poissonnier, Loïc, et al.
Publicado: (2014)

EGFL7 meets miRNA-126: an angiogenesis alliance
por: Nikolic, Iva, et al.
Publicado: (2010)

EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome
por: da Costa, Bruno Henrique Bressan, et al.
Publicado: (2022)

Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation
por: Tang, Chao-Tao, et al.
Publicado: (2020)

Novel Immunotherapies for Osteosarcoma
por: Lu, Yubao, et al.
Publicado: (2022)

Comparative Analysis of Two Surgical Treatment Options for Giant Cell Tumor of the Proximal Femur: Extended Curettage and Segmental Resection
por: Yuan, Yuhao, et al.
Publicado: (2021)

m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma
por: Lin, Zili, et al.
Publicado: (2023)

p53 inhibits CTR1-mediated cisplatin absorption by suppressing SP1 nuclear translocation in osteosarcoma
por: Yong, Lei, et al.
Publicado: (2023)

EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
por: Sung, Ting-Yi, et al.
Publicado: (2021)

egfl6 expression in the pharyngeal pouch is dispensable for craniofacial development
por: Jin, Sil, et al.
Publicado: (2021)

A Distinct Mechanism of Vascular Lumen Formation in Xenopus Requires EGFL7
por: Charpentier, Marta S., et al.
Publicado: (2015)

A Novel Microfluidic Chip for Fast, Sensitive Quantification of Plasma Extracellular Vesicles as Biomarkers in Patients With Osteosarcoma
por: Xu, Yi-Qi, et al.
Publicado: (2021)

NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma
por: Huang, Jin-Cheng, et al.
Publicado: (2017)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
por: Qiu, Cheng, et al.
Publicado: (2022)

Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma
por: Song, Jiaxun, et al.
Publicado: (2022)

Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma
por: Mammola, Caterina L., et al.
Publicado: (2018)

A role for Egfl7 during endothelial organization in the embryoid body model system
por: Durrans, Anna, et al.
Publicado: (2010)

Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study
por: Massimiani, Micol, et al.
Publicado: (2021)

MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression
por: Hu, Ming-Hua, et al.
Publicado: (2016)

Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer
por: de Oliveira, Cristiane, et al.
Publicado: (2023)

Active unicameral bone cysts: control firstly, cure secondly
por: Liu, Qing, et al.
Publicado: (2019)

Intercalary Allograft to Reconstruct Large-Segment Diaphysis Defects After Resection of Lower Extremity Malignant Bone Tumor
por: Liu, Qing, et al.
Publicado: (2020)

Surgical Treatment Options for Giant Cell Tumors of Bone Around the Knee Joint: Extended Curettage or Segmental Resection?
por: He, Hongbo, et al.
Publicado: (2019)

Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments
por: Fanelli, Marilù, et al.
Publicado: (2020)

Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma
por: Fan, Jian, et al.
Publicado: (2021)

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
por: Luo, Zhong-Wei, et al.
Publicado: (2020)

Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
por: He, Chao, et al.
Publicado: (2019)

Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis
por: Manetti, Mirko, et al.
Publicado: (2013)

High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer
por: Pannier, Diane, et al.
Publicado: (2016)

EGFL7 enhances surface expression of integrin α(5)β(1) to promote angiogenesis in malignant brain tumors
por: Dudvarski Stanković, Nevenka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_albf1pdolo7t81b34351nfou0t